# OnCo record nct04712097 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/nct04712097/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "nct04712097", "NCT04712097" ;
  schema:name "A Study Evaluating the Efficacy and Safety of Mosunetuzumab in Combination With Lenalidomide in Comparison to Rituximab in Combination With Lenalidomi"@en ;
  schema:alternateName "Celestimo"@en ;
  schema:description "A phase 3 trial of Mosunetuzumab, Lenalidomide, Rituximab in follicular lymphoma, run by Hoffmann-La Roche, active and no longer recruiting."@en ;
  schema:url <https://onco.cc/trials/nct04712097/> ;
  schema:dateModified "2026-09-16"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT04712097> ;
  onco:status "active" ;
  onco:tag "ctgov-ingest" ;
  onco:phase "3" ;
  schema:startDate "2021-10-27" ;
  onco:cancers <https://onco.cc/cancers/follicular-lymphoma/> ;
  onco:technologies <https://onco.cc/technologies/monoclonal-antibody/>, <https://onco.cc/technologies/protac-degrader/>, <https://onco.cc/technologies/t-cell-engager/> ;
  onco:drugs <https://onco.cc/drugs/mosunetuzumab/>, <https://onco.cc/drugs/lenalidomide/>, <https://onco.cc/drugs/rituximab/> ;
  onco:companies <https://onco.cc/companies/roche-genentech/> .